# Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women

> **NCT00682721** · NA · WITHDRAWN · sponsor: **University of Pittsburgh**

## Conditions studied

- Bacterial Vaginosis
- Herpes Simplex Virus Type II

## Interventions

- **DRUG:** Placebo
- **DRUG:** Valacyclovir

## Key facts

- **NCT ID:** NCT00682721
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-02
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor has withdrawn support for this study and it will not be performed
- **Last updated:** 2012-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00682721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00682721, "Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00682721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*